Case Report: Acute pulmonary embolism complicating tracheobronchial tuberculosis: a case series of five patients
6 affiliations
- 1Department of Tuberculosis, Haihe Hospital, Tianjin University
- 2Department of General Surgery, Haihe Hospital, Tianjin University
- 3Department of Radiology, Haihe Hospital, Tianjin University
- 4Key Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institute of Respiratory Diseases
- 5Department of Basic Medicine, Haihe Clinical School, Tianjin Medical University
- 6Key Laboratory of Lung Regenerative Medicine
Abstract
Background: Tracheobronchial tuberculosis (TBTB) is a distinct airway-involving form of active tuberculosis, yet thromboembolic complications arising during its clinical course remain insufficiently characterized, whereas acute pulmonary embolism (PE) is a potentially life-threatening thromboembolic complication. The coexistence of TBTB and acute PE has rarely been reported, and its clinical features, diagnostic course, and management remain insufficiently described.
Methods: We retrospectively reviewed five consecutive adult patients with TBTB complicated by acute PE who were treated at Tianjin Haihe Hospital between December 2023 and August 2025. All patients had PE confirmed by computed tomography pulmonary angiography (CTPA), and TBTB was established on the basis of chest imaging, microbiological or molecular evidence of Mycobacterium tuberculosis in respiratory specimens, and bronchoscopic or pathological findings. Clinical characteristics, laboratory results, imaging and bronchoscopic findings, treatment patterns, and short-term outcomes were analyzed descriptively.
Results: The five patients included four women and one man, with a mean age of 77 years. PE was diagnosed 7–114 days after TBTB diagnosis (mean, 51 days), and all events occurred during ongoing anti-tuberculosis treatment. Dyspnea was the predominant presenting symptom in all patients, whereas chest pain, hemoptysis, fever, and marked hypoxemia were absent. D-dimer levels were elevated, but most inflammatory and cardiac injury markers were normal. CTPA showed bilateral multiple emboli in three patients, left-sided emboli in one, and right-sided emboli in one; one patient had involvement of the left main pulmonary artery. Four patients had bronchoscopy findings established before referral, and PE was identified during pre-procedural evaluation in most cases. All patients were hemodynamically stable and received immediate anticoagulation with low-molecular-weight heparin followed by rivaroxaban, together with individualized anti-tuberculosis therapy. No major bleeding events were observed during the available follow-up period. One patient developed minor old hemoptysis, and one developed elevated liver enzymes. Overall, the short-term clinical course was favorable, with no documented thrombus progression or death.
Conclusion: Acute PE may occur during the course of TBTB and can present with subtle and nonspecific manifestations, particularly unexplained dyspnea in otherwise stable patients. Early recognition is important because the coexistence of TBTB and PE may complicate diagnostic evaluation, bronchoscopic intervention planning, and anticoagulation during anti-tuberculosis treatment. These cases highlight the need for heightened clinical vigilance and multidisciplinary management in patients with TBTB who develop disproportionate respiratory symptoms during treatment.
Related
- Prognostic Significance of Serum Sodium in Patients With Acute Pulmonary Embolism
- Lifestyle, Dietary Habits, and Modifiable Risk Factors in Patients with Acute Pulmonary Embolism: Protocol for a Prospective Observational Study with Development and Validation of a Composite Lifestyle and Nutrition Questionnaire
- Sex-Based Differences in Clinical Characteristics and Outcomes in Patients with Acute Pulmonary Embolism. An Analysis of 1000 Pulmonary Embolism Response Team Activations
- Outcomes with Catheter-Directed Thrombolysis versus Mechanical Thrombectomy for Patients with Intermediate/High Risk Pulmonary Embolism: A Meta-Analysis of 24,090 Patients.
- CO040 | MAJOR BLEEDING IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: RESULTS FROM THE COPE STUDY
BibTeX
@article{ye2026case,
title = {{Case Report: Acute pulmonary embolism complicating tracheobronchial tuberculosis: a case series of five patients}},
author = {Jing Ye and Jing Li and Zhihua Li and Jigang Wang and Yan Gao and Yi Xie and Xue Li and Huaiyong Chen and Hongxia Shao and Junfeng Han and Junping Wu},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = nov,
doi = {10.3389/fcvm.2026.1896029},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1896029/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Case Report: Acute pulmonary embolism complicating tracheobronchial tuberculosis: a case series of five patients
AU - Jing Ye
AU - Jing Li
AU - Zhihua Li
AU - Jigang Wang
AU - Yan Gao
AU - Yi Xie
AU - Xue Li
AU - Huaiyong Chen
AU - Hongxia Shao
AU - Junfeng Han
AU - Junping Wu
PY - 2026
DA - 2026/11/11
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1896029
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1896029/full
AB - Background: Tracheobronchial tuberculosis (TBTB) is a distinct airway-involving form of active tuberculosis, yet thromboembolic complications arising during its clinical course remain insufficiently characterized, whereas acute pulmonary embolism (PE) is a potentially life-threatening thromboembolic complication. The coexistence of TBTB and acute PE has rarely been reported, and its clinical features, diagnostic course, and management remain insufficiently described. Methods: We retrospectively reviewed five consecutive adult patients with TBTB complicated by acute PE who were treated at Tianjin Haihe Hospital between December 2023 and August 2025. All patients had PE confirmed by computed tomography pulmonary angiography (CTPA), and TBTB was established on the basis of chest imaging, microbiological or molecular evidence of Mycobacterium tuberculosis in respiratory specimens, and bronchoscopic or pathological findings. Clinical characteristics, laboratory results, imaging and bronchoscopic findings, treatment patterns, and short-term outcomes were analyzed descriptively. Results: The five patients included four women and one man, with a mean age of 77 years. PE was diagnosed 7–114 days after TBTB diagnosis (mean, 51 days), and all events occurred during ongoing anti-tuberculosis treatment. Dyspnea was the predominant presenting symptom in all patients, whereas chest pain, hemoptysis, fever, and marked hypoxemia were absent. D-dimer levels were elevated, but most inflammatory and cardiac injury markers were normal. CTPA showed bilateral multiple emboli in three patients, left-sided emboli in one, and right-sided emboli in one; one patient had involvement of the left main pulmonary artery. Four patients had bronchoscopy findings established before referral, and PE was identified during pre-procedural evaluation in most cases. All patients were hemodynamically stable and received immediate anticoagulation with low-molecular-weight heparin followed by rivaroxaban, together with individualized anti-tuberculosis therapy. No major bleeding events were observed during the available follow-up period. One patient developed minor old hemoptysis, and one developed elevated liver enzymes. Overall, the short-term clinical course was favorable, with no documented thrombus progression or death. Conclusion: Acute PE may occur during the course of TBTB and can present with subtle and nonspecific manifestations, particularly unexplained dyspnea in otherwise stable patients. Early recognition is important because the coexistence of TBTB and PE may complicate diagnostic evaluation, bronchoscopic intervention planning, and anticoagulation during anti-tuberculosis treatment. These cases highlight the need for heightened clinical vigilance and multidisciplinary management in patients with TBTB who develop disproportionate respiratory symptoms during treatment.
SN - 2297-055X
ER -